SCHEMBL4530994

SCHEMBL4530994

CC(=O)NCCOc1nc(CCNc2ncnc3[nH]cnc23)cc2cccc(Cl)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2D6 P10635 3/20 0.37
CYP2C19 P33261 3/20 0.37
CLK4 Q9HAZ1 2/20 0.37
MAPK1 P28482 2/20 0.37
HIF1A Q16665 1/20 0.37
ALDH1A1 P00352 3/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HPGD P15428 1/20 0.34
PIK3CD O00329 3/20 0.33
BTK Q06187 2/20 0.33
MTNR1A P48039 4/20 0.33
MTNR1B P49286 4/20 0.33
PIK3CG P48736 2/20 0.32
PIK3R2 O00459 1/20 0.32
PDE10A Q9Y233 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4537519 0.87 KDM4E (0.34) MAPK1LMNAHSD17B10KDM4EPIK3CD
SCHEMBL4534782 0.86 BTK (0.38) CLK4MAPK1LMNAPIK3CDBTK
SCHEMBL3703411 0.83 PIK3R2 (0.39) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3703403 0.83 PIK3R2 (0.39) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL4531006 0.76 SGK1 (0.33) CYP3A4CYP2D6PIK3CDPIK3CGEGFR
SCHEMBL4569394 0.75 PIK3R2 (0.39) PIK3CDPIK3CGPIK3R2ABCB11TBXA2R
SCHEMBL291170 0.73 HTT (0.34) CYP1A2CYP3A4CYP2D6CYP2C19MAPK1
SCHEMBL23019062 0.71 CYP1A2 (0.44) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL864838 0.70 PIK3CD (0.46) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL864839 0.70 PIK3CD (0.46) CYP1A2CYP3A4CYP2D6CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed